NDRG1 and neoplasm: This appears in line with previous reports showing a re-localization of NDRG1 from the plasma membrane to the cytoplasm and nucleus in response to induction of hypoxia, a condition frequently occurring within the tumor microenvironment, that ultimately allows tumors to survive and become resistant to various therapeutic regimens [21].